Intrasense Valuation

Is ALINS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALINS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ALINS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ALINS's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALINS?

Key metric: As ALINS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ALINS. This is calculated by dividing ALINS's market cap by their current revenue.
What is ALINS's PS Ratio?
PS Ratio6.2x
Sales€2.33m
Market Cap€14.67m

Price to Sales Ratio vs Peers

How does ALINS's PS Ratio compare to its peers?

The above table shows the PS ratio for ALINS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.5x
MLLAB Media Lab
3.8xn/a€5.2m
ALMDT Median Technologies
3.1x20.3%€69.1m
CGM Cegedim
0.2x5.2%€153.6m
EQS Equasens Société anonyme
2.9x6.7%€625.3m
ALINS Intrasense
6.3xn/a€14.7m

Price-To-Sales vs Peers: ALINS is expensive based on its Price-To-Sales Ratio (6.2x) compared to the peer average (2.4x).


Price to Sales Ratio vs Industry

How does ALINS's PS Ratio compare vs other companies in the European Healthcare Services Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
ALINS 6.2xIndustry Avg. 2.3xNo. of Companies10PS02.44.87.29.612+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ALINS is expensive based on its Price-To-Sales Ratio (6.2x) compared to the European Healthcare Services industry average (2.3x).


Price to Sales Ratio vs Fair Ratio

What is ALINS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALINS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ALINS's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies